We interrogated MET gene expression and susceptibility to the PARPi olaparib in 547 cancer cell lines reported in the Cancer Cell Line Encyclopedia (CCLE) project database [24], available through the tools for CCLE Data Visualization and Analysis DepMap portal (https://depmap.org/portal (accessed on 17 May 2022)). The gene discussed is MET; the disease is cancer.